Research focus
About the research
How can stem and progenitor cell biology be used to treat neurological diseases through cell and gene therapy?
Read the full research overview
The goal of Steven Goldman's division is to understand the regulatory control of stem and progenitor cells of the human CNS and to use that knowledge to design new approaches for treating neurological diseases. One focus is on glial disorders potentially modifiable through a better understanding of glial progenitor cell biology. Demyelinating disease is studied as a potential target for oligodendrocyte progenitor cell delivery, while Huntington's disease is studied as a potential beneficiary of medium spiny neuronal replacement from endogenous stem cells. The lab also studies adult neurogenesis in both songbird and mammalian models.
Selected publications
3 listedReactive astrocyte nomenclature, definitions, and future directions
Nature Neuroscience
Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes
Nature Communications
Potentiating glymphatic drainage minimizes post-traumatic cerebral oedema
Nature
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings